Therapies for interstitial lung disease: past, present and future. - Wikidata - awgldk - TriplyDB

Therapies for interstitial lung disease: past, present and future.

Therapies for interstitial lung disease: past, present and future.

http://www.wikidata.org/entity/Q37362642

about

Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.Signaling pathways in the epithelial origins of pulmonary fibrosis Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs.Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation.Overexpression of Sulf2 in idiopathic pulmonary fibrosis Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis TGF-β: Titan of Lung Fibrogenesis.Diagnosis and management of interstitial lung disease.Psycho-Physiological Associates of Dyspnea in Hospitalized Patients with Interstitial Lung Diseases: A Cross-Sectional Study.Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency.JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis.

P2860

Q34321160-45EF0318-5828-462F-B3EB-4D733EAF1C22 Q34582154-15912698-42C2-405E-9A01-0FA9AED35C85 Q34917680-AA6B4076-E5BE-436B-A4AC-1D99750AAC98 Q34955112-C86AA9DD-5300-45C0-828B-3ADC52B2B0C9 Q35103903-9389EA21-334F-4132-9DA7-58144420399C Q35144563-AF2866BF-7DB1-468F-8BC9-51D526FF3818 Q35790008-ECAF1740-E988-45D9-80E4-D7BCC9483F60 Q36811065-228BA684-044B-4C50-B7C8-763C62CB039D Q37523472-54654334-464D-43D0-9C04-1E691B4F4790 Q37596106-3810B5E5-EE13-496E-829D-59742D6A0CFE Q38159689-55CE2EF8-12BE-4236-B829-1A47E7EF13E0 Q38288028-7900802D-EA34-4DC5-B40E-CFB178AB4869 Q47104446-F66620B0-5DD6-42EB-A500-90B43D6AD7B1 Q51006342-11F5911C-7641-43F5-92BE-FAED64CB23D6 Q54513818-EF86ED04-198A-4815-9AC7-67C446B319D8

P2860

Therapies for interstitial lung disease: past, present and future.

http://www.wikidata.org/entity/Q37362642

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapies for interstitial lung disease: past, present and future.

@en

Therapies for interstitial lung disease: past, present and future.

@nl

type

label

Therapies for interstitial lung disease: past, present and future.

@en

Therapies for interstitial lung disease: past, present and future.

@nl

prefLabel

Therapies for interstitial lung disease: past, present and future.

@en

Therapies for interstitial lung disease: past, present and future.

@nl

P1433

Q37362642-740B705E-F449-4B70-AEA3-351352B284A4

P1476

Q37362642-46D85DBB-6A7A-4F26-A53D-FBAB00A4DCE1

P2093

Q37362642-D14C57A8-551A-4E46-A260-1828F2C78510

Q37362642-F65F2CB7-ADA1-4DEF-A4A7-8717362AD35B

P2860

Q37362642-038D216C-571D-49AF-9E65-95B455453963

Q37362642-08E60649-2888-4D87-B8D1-722276CB5547

Q37362642-0B0CD929-43E9-4C86-AFAE-47B8DF8D1FEF

Q37362642-0FCA71FD-BC53-4076-984C-6610A1AE7BC6

Q37362642-186E3498-3E2A-43D7-9661-4853091E0FBE

Q37362642-18DF5EF9-3195-44C5-9844-DCDC2394C1A3

Q37362642-1E218233-DC8B-43C3-BC17-903D87859237

Q37362642-20BCC069-57FB-448C-A3F4-9A20D8DEBDDF

Q37362642-25243973-1529-4088-A6EF-01398F9EF9A3

Q37362642-2872759F-0F71-4EE1-BD79-D42EC7739874

P304

Q37362642-1D2BB5D5-87F2-4DD9-9BC7-32A559659376

P31

Q37362642-94290A11-3BA3-4556-BE00-63879CDF7901

P356

Q37362642-E2BEF08E-5408-41BD-9275-E65B56A306C2

P433

Q37362642-26B61390-8052-440B-8EE7-46D90733F087

P478

Q37362642-D1BDB589-2798-4190-A8EE-9C2118B149A0

P577

Q37362642-FD6AE87A-5A11-4FE9-A8B6-BC0C55A9FEAD

P698

Q37362642-B6EF3C16-9C72-4E76-84A2-3B8D5F4A7B3C

P356

1753465808096948

P1433

Therapeutic advances in respiratory disease

P1476

Therapies for interstitial lung disease: past, present and future.

@en

P2093

Keith C Meyer

http://www.w3.org/2001/XMLSchema#string

Robert Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis

Corticosteroids for idiopathic pulmonary fibrosis

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

High-dose acetylcysteine in idiopathic pulmonary fibrosis

Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages

Sirolimus--challenging current perspectives.

Corticosteroids for pulmonary sarcoidosis.

P304

319-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753465808096948

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19124380

http://www.w3.org/2001/XMLSchema#string